首页|IDO1介导的色氨酸代谢在脓毒症中的研究进展

IDO1介导的色氨酸代谢在脓毒症中的研究进展

扫码查看
脓毒症是由感染引起的全身炎症反应导致的器官功能障碍,过度炎症和免疫抑制交织存在,严重者甚至可发展为多器官功能衰竭。研究表明,吲哚胺-2,3-双加氧酶1(indoleamine 2,3-dioxygenase 1,IDO1)介导的色氨酸代谢参与了脓毒症的发生发展过程,血浆犬尿氨酸水平和犬尿氨酸/色氨酸(kynurenine/tryptophan,Kyn/Trp)比值升高是败血症发展的早期指标。本文系统总结了 IDO1在脓毒症急性炎症期、后期免疫抑制及器官损害过程中所发挥的作用,主要包括对炎症状态、免疫细胞功能、血压及其他环节的调节,同时对靶向IDO1药物临床前研究进行了分析。深入了解和研究IDO1可能有助于从全新的角度认识脓毒症和多器官损害的发病机制及临床意义,并为探索其防治方法提供新的研究思路。
Research progress of IDO1-mediated tryptophan metabolism in sepsis
Sepsis is a condition characterized by organ dysfunction resulting from the systemic inflammatory response triggered by an infection.Excessive inflammation and immunosuppression are intertwined,and severe cases may even develop into multiple organ failure.Studies have shown that indoleamine 2,3-dioxygenase 1-mediated tryptophan metabolism is involved in the occurrence and development of sepsis,and elevated plasma kynurenine levels and Kyn/Trp ratios are early indicators of sepsis development.In this paper,we provide a comprehensive summary of the role of IDO1 in the acute inflammatory phase of sepsis,late immunosuppression,and organ damage.This includes its regulation of inflammatory state,immune cell function,blood pressure,and other aspects.Additionally,we analyze preclinical studies on targeted IDO1 drugs.An in-depth understanding and study of IDO may help to understand the pathogenesis and clinical significance of sepsis and multiple organ damage from a new perspective and provide new research ideas for exploring its prevention and treatment methods.

sepsisindoleamine 2,3-dioxygenase 1immune activationinflammationhypotension

赵晓迪、马铖延、崔华清、王雨辰、陈晓光、张森

展开 >

中国医学科学院、北京协和医学院药物研究所,天然药物活性物质与功能国家重点实验室,北京 100050

中国医学科学院、北京协和医学院医学实验动物研究所,北京 100021

脓毒症 吲哚胺-2,3-双加氧酶1 免疫激活 炎症 低血压

中国医科院创新工程项目北京协和医学院中央高校基本科研业务费专项

2022-I2M-1-0143332022045

2024

药学学报
中国药学会 中国医学科学院药物研究所

药学学报

CSTPCD北大核心
影响因子:1.274
ISSN:0513-4870
年,卷(期):2024.59(2)
  • 73